pubmed-article:19405813 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19405813 | lifeskim:mentions | umls-concept:C0026845 | lld:lifeskim |
pubmed-article:19405813 | lifeskim:mentions | umls-concept:C1457899 | lld:lifeskim |
pubmed-article:19405813 | lifeskim:mentions | umls-concept:C0205245 | lld:lifeskim |
pubmed-article:19405813 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
pubmed-article:19405813 | lifeskim:mentions | umls-concept:C1705822 | lld:lifeskim |
pubmed-article:19405813 | lifeskim:mentions | umls-concept:C0348011 | lld:lifeskim |
pubmed-article:19405813 | lifeskim:mentions | umls-concept:C0181586 | lld:lifeskim |
pubmed-article:19405813 | lifeskim:mentions | umls-concept:C0439834 | lld:lifeskim |
pubmed-article:19405813 | lifeskim:mentions | umls-concept:C0456962 | lld:lifeskim |
pubmed-article:19405813 | lifeskim:mentions | umls-concept:C0205373 | lld:lifeskim |
pubmed-article:19405813 | lifeskim:mentions | umls-concept:C1709708 | lld:lifeskim |
pubmed-article:19405813 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:19405813 | pubmed:dateCreated | 2009-5-7 | lld:pubmed |
pubmed-article:19405813 | pubmed:abstractText | Myostatin is a member of the transformating growth factor-beta (TGF-beta) superfamily of proteins and is produced almost exclusively in skeletal muscle tissue, where it is secreted and circulates as a serum protein. Myostatin acts as a negative regulator of muscle mass through the canonical SMAD2/3/4 signaling pathway. Naturally occurring myostatin mutants exhibit a 'double muscling' phenotype in which muscle mass is dramatically increased as a result of both hypertrophy and hyperplasia. Myostatin is naturally inhibited by its own propeptide; therefore, we assessed the impact of adeno-associated virus-8 (AAV8) myostatin propeptide vectors when systemically introduced in MF-1 mice. We noted a significant systemic increase in muscle mass in both slow and fast muscle phenotypes, with no evidence of hyperplasia; however, the nuclei-to- cytoplasm ratio in all myofiber types was significantly reduced. An increase in muscle mass in slow (soleus) muscle led to an increase in force output; however, an increase in fast (extensor digitorum longus [EDL]) muscle mass did not increase force output. These results suggest that the use of gene therapeutic regimens of myostatin inhibition for age-related or disease-related muscle loss may have muscle-specific effects. | lld:pubmed |
pubmed-article:19405813 | pubmed:language | eng | lld:pubmed |
pubmed-article:19405813 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19405813 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19405813 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19405813 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19405813 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19405813 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19405813 | pubmed:month | Apr | lld:pubmed |
pubmed-article:19405813 | pubmed:issn | 1557-8577 | lld:pubmed |
pubmed-article:19405813 | pubmed:author | pubmed-author:LuberitzBB | lld:pubmed |
pubmed-article:19405813 | pubmed:author | pubmed-author:PatelKetanK | lld:pubmed |
pubmed-article:19405813 | pubmed:author | pubmed-author:GrahamIan RIR | lld:pubmed |
pubmed-article:19405813 | pubmed:author | pubmed-author:DicksonGeorge... | lld:pubmed |
pubmed-article:19405813 | pubmed:author | pubmed-author:WalshFrank... | lld:pubmed |
pubmed-article:19405813 | pubmed:author | pubmed-author:FosterHelenH | lld:pubmed |
pubmed-article:19405813 | pubmed:author | pubmed-author:YaworskyPaul... | lld:pubmed |
pubmed-article:19405813 | pubmed:author | pubmed-author:FosterKeithK | lld:pubmed |
pubmed-article:19405813 | pubmed:author | pubmed-author:TrolletCapuci... | lld:pubmed |
pubmed-article:19405813 | pubmed:author | pubmed-author:OttoAnthonyA | lld:pubmed |
pubmed-article:19405813 | pubmed:author | pubmed-author:BickhamDaleD | lld:pubmed |
pubmed-article:19405813 | pubmed:author | pubmed-author:KawarSusannah... | lld:pubmed |
pubmed-article:19405813 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19405813 | pubmed:volume | 12 | lld:pubmed |
pubmed-article:19405813 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19405813 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19405813 | pubmed:pagination | 85-94 | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:meshHeading | pubmed-meshheading:19405813... | lld:pubmed |
pubmed-article:19405813 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19405813 | pubmed:articleTitle | Adeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscle. | lld:pubmed |
pubmed-article:19405813 | pubmed:affiliation | SWAN Institute of Biomedical and Life Sciences, School of Biological Sciences, Royal Holloway-University of London, Egham, UK. | lld:pubmed |
pubmed-article:19405813 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19405813 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19405813 | lld:pubmed |